Controlled Substances

CS/CS/HB 309 2026

CODING: Words stricken are deletions; words underlined are additions.
hb309-02-c2
Page 1 of 49
F L O R I D A H O U S E O F R E P R E S E N T A T I V E S

A bill to be entitled 1
An act relating to controlled substances; amending s. 2
893.03, F.S.; excepting from the list of Schedule I 3
controlled substances certain xylazine animal drug 4
products approved by the United States Food and Drug 5
Administration and used for certain purposes; amending 6
s. 893.13, F.S.; providing criminal penalties and 7
requiring a mandatory minimum term of imprisonment if 8
a person sells, manufactures, or delivers or possesses 9
with intent to sell, manufacture, or deliver xylazine; 10
amending s. 893.135, F.S.; creating the offense of 11
trafficking in xylazine; providing criminal penalties 12
and requiring a mandatory minimum term of imprisonment 13
and fines based on the quantity of the controlled 14
substance involved in the offense; providing effective 15
dates. 16
17
Be It Enacted by the Legislature of the State of Florida: 18
19
Section 1. Effective July 1, 2026, paragraph (c) of 20
subsection (1) of section 893.03, Florida Statutes, is amended 21
to read: 22
893.03 Standards and schedules.—The substances enumerated 23
in this section are controlled by this chapter. The controlled 24
substances listed or to be listed in Schedules I, II, III, IV, 25

CS/CS/HB 309 2026

CODING: Words stricken are deletions; words underlined are additions.
hb309-02-c2
Page 2 of 49
F L O R I D A H O U S E O F R E P R E S E N T A T I V E S

and V are included by whatever official, common, usual, 26
chemical, trade name, or class designated. The provisions of 27
this section shall not be construed to include within any of the 28
schedules contained in this section any excluded drugs listed 29
within the purview of 21 C.F.R. s. 1308.22, styled "Excluded 30
Substances"; 21 C.F.R. s. 1308.24, styled "Exempt Chemical 31
Preparations"; 21 C.F.R. s. 1308.32, styled "Exempted 32
Prescription Products"; or 21 C.F.R. s. 1308.34, styled "Exempt 33
Anabolic Steroid Products." 34
(1) SCHEDULE I.—A substance in Schedule I has a high 35
potential for abuse and has no currently accepted medical use in 36
treatment in the United States and in its use under medical 37
supervision does not meet accepted safety standards. The 38
following substances are controlled in Schedule I: 39
(c) Unless specifically excepted or unless listed in 40
another schedule, any material, compound, mixture, or 41
preparation that contains any quantity of the following 42
hallucinogenic substances or that contains any of their salts, 43
isomers, including optical, positional, or geometric isomers, 44
homologues, nitrogen-heterocyclic analogs, esters, ethers, and 45
salts of isomers, homologues, nitrogen-heterocyclic analogs, 46
esters, or ethers, if the existence of such salts, isomers, and 47
salts of isomers is possible within the specific chemical 48
designation or class description: 49
1. Alpha-Ethyltryptamine. 50

CS/CS/HB 309 2026

CODING: Words stricken are deletions; words underlined are additions.
hb309-02-c2
Page 3 of 49
F L O R I D A H O U S E O F R E P R E S E N T A T I V E S

2. 4-Methylaminorex (2-Amino-4-methyl-5-phenyl-2-51
oxazoline). 52
3. Aminorex (2-Amino-5-phenyl-2-oxazoline). 53
4. DOB (4-Bromo-2,5-dimethoxyamphetamine). 54
5. 2C-B (4-Bromo-2,5-dimethoxyphenethylamine). 55
6. Bufotenine. 56
7. Cannabis. 57
8. Cathinone. 58
9. DET (Diethyltryptamine). 59
10. 2,5-Dimethoxyamphetamine. 60
11. DOET (4-Ethyl-2,5-Dimethoxyamphetamine). 61
12. DMT (Dimethyltryptamine). 62
13. PCE (N-Ethyl-1-phenylcyclohexylamine) (Ethylamine 63
analog of phencyclidine). 64
14. JB-318 (N-Ethyl-3-piperidyl benzilate). 65
15. N-Ethylamphetamine. 66
16. Fenethylline. 67
17. 3,4-Methylenedioxy-N-hydroxyamphetamine. 68
18. Ibogaine. 69
19. LSD (Lysergic acid diethylamide). 70
20. Mescaline. 71
21. Methcathinone. 72
22. 5-Methoxy-3,4-methylenedioxyamphetamine. 73
23. PMA (4-Methoxyamphetamine). 74
24. PMMA (4-Methoxymethamphetamine). 75

CS/CS/HB 309 2026

CODING: Words stricken are deletions; words underlined are additions.
hb309-02-c2
Page 4 of 49
F L O R I D A H O U S E O F R E P R E S E N T A T I V E S

25. DOM (4-Methyl-2,5-dimethoxyamphetamine). 76
26. MDEA (3,4-Methylenedioxy-N-ethylamphetamine). 77
27. MDA (3,4-Methylenedioxyamphetamine). 78
28. JB-336 (N-Methyl-3-piperidyl benzilate). 79
29. N,N-Dimethylamphetamine. 80
30. Parahexyl. 81
31. Peyote. 82
32. PCPY (N-(1-Phenylcyclohexyl)-pyrrolidine) (Pyrrolidine 83
analog of phencyclidine). 84
33. Psilocybin. 85
34. Psilocyn. 86
35. Salvia divinorum, except for any drug product approved 87
by the United States Food and Drug Administration which contains 88
Salvia divinorum or its isomers, esters, ethers, salts, and 89
salts of isomers, esters, and ethers, if the existence of such 90
isomers, esters, ethers, and salts is possible within the 91
specific chemical designation. 92
36. Salvinorin A, except for any drug product approved by 93
the United States Food and Drug Administration which contains 94
Salvinorin A or its isomers, esters, ethers, salts, and salts of 95
isomers, esters, and ethers, if the existence of such isomers, 96
esters, ethers, and salts is possible within the specific 97
chemical designation. 98
37. Xylazine, except for a xylazine animal drug product 99
approved by the United States Food and Drug Administration and 100

CS/CS/HB 309 2026

CODING: Words stricken are deletions; words underlined are additions.
hb309-02-c2
Page 5 of 49
F L O R I D A H O U S E O F R E P R E S E N T A T I V E S

the use of which conforms to the approved application or is 101
authorized under 21 U.S.C. s. 360b(a)(4). The manufacture, 102
importation, distribution, prescribing, or sale of xylazine for 103
human use is not subject to this exception. 104
38. TCP (1-[1-(2-Thienyl)-cyclohexyl]-piperidine) 105
(Thiophene analog of phencyclidine). 106
39. 3,4,5-Trimethoxyamphetamine. 107
40. Methylone (3,4-Methylenedioxymethcathinone). 108
41. MDPV (3,4-Methylenedioxypyrovalerone). 109
42. Methylmethcathinone. 110
43. Methoxymethcathinone. 111
44. Fluoromethcathinone. 112
45. Methylethcathinone. 113
46. CP 47,497 (2-(3-Hydroxycyclohexyl)-5-(2-methyloctan-2-114
yl)phenol) and its dimethyloctyl (C8) homologue. 115
47. HU-210 [(6aR,10aR)-9-(Hydroxymethyl)-6,6-dimethyl-3-116
(2-methyloctan-2-yl)-6a,7,10,10a-tetrahydrobenzo[c]chromen-1-117
ol]. 118
48. JWH-018 (1-Pentyl-3-(1-naphthoyl)indole). 119
49. JWH-073 (1-Butyl-3-(1-naphthoyl)indole). 120
50. JWH-200 (1-[2-(4-Morpholinyl)ethyl]-3-(1-121
naphthoyl)indole). 122
51. BZP (Benzylpiperazine). 123
52. Fluorophenylpiperazine. 124
53. Methylphenylpiperazine. 125

CS/CS/HB 309 2026

CODING: Words stricken are deletions; words underlined are additions.
hb309-02-c2
Page 6 of 49
F L O R I D A H O U S E O F R E P R E S E N T A T I V E S

54. Chlorophenylpiperazine. 126
55. Methoxyphenylpiperazine. 127
56. DBZP (1,4-Dibenzylpiperazine). 128
57. TFMPP (Trifluoromethylphenylpiperazine). 129
58. MBDB (Methylbenzodioxolylbutanamine) or (3,4-130
Methylenedioxy-N-methylbutanamine). 131
59. 5-Hydroxy-AMT (5-Hydroxy-alpha-methyltryptamine). 132
60. 5-Hydroxy-N-methyltryptamine. 133
61. 5-MeO-MiPT (5-Methoxy-N-methyl-N-isopropyltryptamine). 134
62. 5-MeO-AMT (5-Methoxy-alpha-methyltryptamine). 135
63. Methyltryptamine. 136
64. 5-MeO-DMT (5-Methoxy-N,N-dimethyltryptamine). 137
65. 5-Me-DMT (5-Methyl-N,N-dimethyltryptamine). 138
66. Tyramine (4-Hydroxyphenethylamine). 139
67. 5-MeO-DiPT (5-Methoxy-N,N-Diisopropyltryptamine). 140
68. DiPT (N,N-Diisopropyltryptamine). 141
69. DPT (N,N-Dipropyltryptamine). 142
70. 4-Hydroxy-DiPT (4-Hydroxy-N,N-diisopropyltryptamine). 143
71. 5-MeO-DALT (5-Methoxy-N,N-Diallyltryptamine). 144
72. DOI (4-Iodo-2,5-dimethoxyamphetamine). 145
73. DOC (4-Chloro-2,5-dimethoxyamphetamine). 146
74. 2C-E (4-Ethyl-2,5-dimethoxyphenethylamine). 147
75. 2C-T-4 (4-Isopropylthio-2,5-dimethoxyphenethylamine). 148
76. 2C-C (4-Chloro-2,5-dimethoxyphenethylamine). 149
77. 2C-T (4-Methylthio-2,5-dimethoxyphenethylamine). 150

CS/CS/HB 309 2026

CODING: Words stricken are deletions; words underlined are additions.
hb309-02-c2
Page 7 of 49
F L O R I D A H O U S E O F R E P R E S E N T A T I V E S

78. 2C-T-2 (4-Ethylthio-2,5-dimethoxyphenethylamine). 151
79. 2C-T-7 (4-(n)-Propylthio-2,5-dimethoxyphenethylamine). 152
80. 2C-I (4-Iodo-2,5-dimethoxyphenethylamine). 153
81. Butylone (3,4-Methylenedioxy-alpha-154
methylaminobutyrophenone). 155
82. Ethcathinone. 156
83. Ethylone (3,4-Methylenedioxy-N-ethylcathinone). 157
84. Naphyrone (Naphthylpyrovalerone). 158
85. Dimethylone (3,4-Methylenedioxy-N,N-159
dimethylcathinone). 160
86. 3,4-Methylenedioxy-N,N-diethylcathinone. 161
87. 3,4-Methylenedioxy-propiophenone. 162
88. 3,4-Methylenedioxy-alpha-bromopropiophenone. 163
89. 3,4-Methylenedioxy-propiophenone-2-oxime. 164
90. 3,4-Methylenedioxy-N-acetylcathinone. 165
91. 3,4-Methylenedioxy-N-acetylmethcathinone. 166
92. 3,4-Methylenedioxy-N-acetylethcathinone. 167
93. Bromomethcathinone. 168
94. Buphedrone (alpha-Methylamino-butyrophenone). 169
95. Eutylone (3,4-Methylenedioxy-alpha-170
ethylaminobutyrophenone). 171
96. Dimethylcathinone. 172
97. Dimethylmethcathinone. 173
98. Pentylone (3,4-Methylenedioxy-alpha-174
methylaminovalerophenone). 175

CS/CS/HB 309 2026

CODING: Words stricken are deletions; words underlined are additions.
hb309-02-c2
Page 8 of 49
F L O R I D A H O U S E O F R E P R E S E N T A T I V E S

99. MDPPP (3,4-Methylenedioxy-alpha-176
pyrrolidinopropiophenone). 177
100. MDPBP (3,4-Methylenedioxy-alpha-178
pyrrolidinobutyrophenone). 179
101. MOPPP (Methoxy-alpha-pyrrolidinopropiophenone). 180
102. MPHP (Methyl-alpha-pyrrolidinohexanophenone). 181
103. BTCP (Benzothiophenylcyclohexylpiperidine) or BCP 182
(Benocyclidine). 183
104. F-MABP (Fluoromethylaminobutyrophenone). 184
105. MeO-PBP (Methoxypyrrolidinobutyrophenone). 185
106. Et-PBP (Ethylpyrrolidinobutyrophenone). 186
107. 3-Me-4-MeO-MCAT (3-Methyl-4-Methoxymethcathinone). 187
108. Me-EABP (Methylethylaminobutyrophenone). 188
109. Etizolam. 189
110. PPP (Pyrrolidinopropiophenone). 190
111. PBP (Pyrrolidinobutyrophenone). 191
112. PVP (Pyrrolidinovalerophenone) or 192
(Pyrrolidinopentiophenone). 193
113. MPPP (Methyl-alpha-pyrrolidinopropiophenone). 194
114. JWH-007 (1-Pentyl-2-methyl-3-(1-naphthoyl)indole). 195
115. JWH-015 (1-Propyl-2-methyl-3-(1-naphthoyl)indole). 196
116. JWH-019 (1-Hexyl-3-(1-naphthoyl)indole). 197
117. JWH-020 (1-Heptyl-3-(1-naphthoyl)indole). 198
118. JWH-072 (1-Propyl-3-(1-naphthoyl)indole). 199
119. JWH-081 (1-Pentyl-3-(4-methoxy-1-naphthoyl)indole). 200

CS/CS/HB 309 2026

CODING: Words stricken are deletions; words underlined are additions.
hb309-02-c2
Page 9 of 49
F L O R I D A H O U S E O F R E P R E S E N T A T I V E S

120. JWH-122 (1-Pentyl-3-(4-methyl-1-naphthoyl)indole). 201
121. JWH-133 ((6aR,10aR)-6,6,9-Trimethyl-3-(2-202
methylpentan-2-yl)-6a,7,10,10a-tetrahydrobenzo[c]chromene). 203
122. JWH-175 (1-Pentyl-3-(1-naphthylmethyl)indole). 204
123. JWH-201 (1-Pentyl-3-(4-methoxyphenylacetyl)indole). 205
124. JWH-203 (1-Pentyl-3-(2-chlorophenylacetyl)indole). 206
125. JWH-210 (1-Pentyl-3-(4-ethyl-1-naphthoyl)indole). 207
126. JWH-250 (1-Pentyl-3-(2-methoxyphenylacetyl)indole). 208
127. JWH-251 (1-Pentyl-3-(2-methylphenylacetyl)indole). 209
128. JWH-302 (1-Pentyl-3-(3-methoxyphenylacetyl)indole). 210
129. JWH-398 (1-Pentyl-3-(4-chloro-1-naphthoyl)indole). 211
130. HU-211 ((6aS,10aS)-9-(Hydroxymethyl)-6,6-dimethyl-3-212
(2-methyloctan-2-yl)-6a,7,10,10a-tetrahydrobenzo[c]chromen-1-213
ol). 214
131. HU-308 ([(1R,2R,5R)-2-[2,6-Dimethoxy-4-(2-215
methyloctan-2-yl)phenyl]-7,7-dimethyl-4-bicyclo[3.1.1]hept-3-216
enyl] methanol). 217
132. HU-331 (3-Hydroxy-2-[(1R,6R)-3-methyl-6-(1-218
methylethenyl)-2-cyclohexen-1-yl]-5-pentyl-2,5-cyclohexadiene-219
1,4-dione). 220
133. CB-13 (4-Pentyloxy-1-(1-naphthoyl)naphthalene). 221
134. CB-25 (N-Cyclopropyl-11-(3-hydroxy-5-pentylphenoxy)-222
undecanamide). 223
135. CB-52 (N-Cyclopropyl-11-(2-hexyl-5-hydroxyphenoxy)-224
undecanamide). 225

CS/CS/HB 309 2026

CODING: Words stricken are deletions; words underlined are additions.
hb309-02-c2
Page 10 of 49
F L O R I D A H O U S E O F R E P R E S E N T A T I V E S

136. CP 55,940 (2-[3-Hydroxy-6-propanol-cyclohexyl]-5-(2-226
methyloctan-2-yl)phenol). 227
137. AM-694 (1-(5-Fluoropentyl)-3-(2-iodobenzoyl)indole). 228
138. AM-2201 (1-(5-Fluoropentyl)-3-(1-naphthoyl)indole). 229
139. RCS-4 (1-Pentyl-3-(4-methoxybenzoyl)indole). 230
140. RCS-8 (1-(2-Cyclohexylethyl)-3-(2-231
methoxyphenylacetyl)indole). 232
141. WIN55,212-2 ((R)-(+)-[2,3-Dihydro-5-methyl-3-(4-233
morpholinylmethyl)pyrrolo[1,2,3-de]-1,4-benzoxazin-6-yl]-1-234
naphthalenylmethanone). 235
142. WIN55,212-3 ([(3S)-2,3-Dihydro-5-methyl-3-(4-236
morpholinylmethyl)pyrrolo[1,2,3-de]-1,4-benzoxazin-6-yl]-1-237
naphthalenylmethanone). 238
143. Pentedrone (alpha-Methylaminovalerophenone). 239
144. Fluoroamphetamine. 240
145. Fluoromethamphetamine. 241
146. Methoxetamine. 242
147. Methiopropamine. 243
148. Methylbuphedrone (Methyl-alpha-244
methylaminobutyrophenone). 245
149. APB ((2-Aminopropyl)benzofuran). 246
150. APDB ((2-Aminopropyl)-2,3-dihydrobenzofuran). 247
151. UR-144 (1-Pentyl-3-(2,2,3,3-248
tetramethylcyclopropanoyl)indole). 249
152. XLR11 (1-(5-Fluoropentyl)-3-(2,2,3,3-250

CS/CS/HB 309 2026

CODING: Words stricken are deletions; words underlined are additions.
hb309-02-c2
Page 11 of 49
F L O R I D A H O U S E O F R E P R E S E N T A T I V E S

tetramethylcyclopropanoyl)indole). 251
153. Chloro UR-144 (1-(Chloropentyl)-3-(2,2,3,3-252
tetramethylcyclopropanoyl)indole). 253
154. AKB48 (N-Adamant-1-yl 1-pentylindazole-3-254
carboxamide). 255
155. AM-2233(1-[(N-Methyl-2-piperidinyl)methyl]-3-(2-256
iodobenzoyl)indole). 257
156. STS-135 (N-Adamant-1-yl 1-(5-fluoropentyl)indole-3-258
carboxamide). 259
157. URB-597 ((3′-(Aminocarbonyl)[1,1′-biphenyl]-3-yl)-260
cyclohexylcarbamate). 261
158. URB-602 ([1,1′-Biphenyl]-3-yl-carbamic acid, 262
cyclohexyl ester). 263
159. URB-754 (6-Methyl-2-[(4-methylphenyl)amino]-1-264
benzoxazin-4-one). 265
160. 2C-D (4-Methyl-2,5-dimethoxyphenethylamine). 266
161. 2C-H (2,5-Dimethoxyphenethylamine). 267
162. 2C-N (4-Nitro-2,5-dimethoxyphenethylamine). 268
163. 2C-P (4-(n)-Propyl-2,5-dimethoxyphenethylamine). 269
164. 25I-NBOMe (4-Iodo-2,5-dimethoxy-[N-(2-270
methoxybenzyl)]phenethylamine). 271
165. MDMA (3,4-Methylenedioxymethamphetamine). 272
166. PB-22 (8-Quinolinyl 1-pentylindole-3-carboxylate). 273
167. Fluoro PB-22 (8-Quinolinyl 1-(fluoropentyl)indole-3-274
carboxylate). 275

CS/CS/HB 309 2026

CODING: Words stricken are deletions; words underlined are additions.
hb309-02-c2
Page 12 of 49
F L O R I D A H O U S E O F R E P R E S E N T A T I V E S

168. BB-22 (8-Quinolinyl 1-(cyclohexylmethyl)indole-3-276
carboxylate). 277
169. Fluoro AKB48 (N-Adamant-1-yl 1-278
(fluoropentyl)indazole-3-carboxamide). 279
170. AB-PINACA (N-(1-Amino-3-methyl-1-oxobutan-2-yl)-1-280
pentylindazole-3-carboxamide). 281
171. AB-FUBINACA (N-(1-Amino-3-methyl-1-oxobutan-2-yl)-1-282
(4-fluorobenzyl)indazole-3-carboxamide). 283
172. ADB-PINACA (N-(1-Amino-3,3-dimethyl-1-oxobutan-2-yl)-284
1-pentylindazole-3-carboxamide). 285
173. Fluoro ADBICA (N-(1-Amino-3,3-dimethyl-1-oxobutan-2-286
yl)-1-(fluoropentyl)indole-3-carboxamide). 287
174. 25B-NBOMe (4-Bromo-2,5-dimethoxy-[N-(2-288
methoxybenzyl)]phenethylamine). 289
175. 25C-NBOMe (4-Chloro-2,5-dimethoxy-[N-(2-290
methoxybenzyl)]phenethylamine). 291
176. AB-CHMINACA (N-(1-Amino-3-methyl-1-oxobutan-2-yl)-1-292
(cyclohexylmethyl)indazole-3-carboxamide). 293
177. FUB-PB-22 (8-Quinolinyl 1-(4-fluorobenzyl)indole-3-294
carboxylate). 295
178. Fluoro-NNEI (N-Naphthalen-1-yl 1-296
(fluoropentyl)indole-3-carboxamide). 297
179. Fluoro-AMB (N-(1-Methoxy-3-methyl-1-oxobutan-2-yl)-1-298
(fluoropentyl)indazole-3-carboxamide). 299
180. THJ-2201 (1-(5-Fluoropentyl)-3-(1-300

CS/CS/HB 309 2026

CODING: Words stricken are deletions; words underlined are additions.
hb309-02-c2
Page 13 of 49
F L O R I D A H O U S E O F R E P R E S E N T A T I V E S

naphthoyl)indazole). 301
181. AM-855 ((4aR,12bR)-8-Hexyl-2,5,5-trimethyl-302
1,4,4a,8,9,10,11,12b-octahydronaphtho[3,2-c]isochromen-12-ol). 303
182. AM-905 ((6aR,9R,10aR)-3-[(E)-Hept-1-enyl]-9-304
(hydroxymethyl)-6,6-dimethyl-6a,7,8,9,10,10a-305
hexahydrobenzo[c]chromen-1-ol). 306
183. AM-906 ((6aR,9R,10aR)-3-[(Z)-Hept-1-enyl]-9-307
(hydroxymethyl)-6,6-dimethyl-6a,7,8,9,10,10a-308
hexahydrobenzo[c]chromen-1-ol). 309
184. AM-2389 ((6aR,9R,10aR)-3-(1-Hexyl-cyclobut-1-yl)-310
6a,7,8,9,10,10a-hexahydro-6,6-dimethyl-6H-dibenzo[b,d]pyran-1,9 311
diol). 312
185. HU-243 ((6aR,8S,9S,10aR)-9-(Hydroxymethyl)-6,6-313
dimethyl-3-(2-methyloctan-2-yl)-8,9-ditritio-7,8,10,10a-314
tetrahydro-6aH-benzo[c]chromen-1-ol). 315
186. HU-336 ((6aR,10aR)-6,6,9-Trimethyl-3-pentyl-316
6a,7,10,10a-tetrahydro-1H-benzo[c]chromene-1,4(6H)-dione). 317
187. MAPB ((2-Methylaminopropyl)benzofuran). 318
188. 5-IT (2-(1H-Indol-5-yl)-1-methyl-ethylamine). 319
189. 6-IT (2-(1H-Indol-6-yl)-1-methyl-ethylamine). 320
190. Synthetic Cannabinoids.—Unless specifically excepted 321
or unless listed in another schedule or contained within a 322
pharmaceutical product approved by the United States Food and 323
Drug Administration, any material, compound, mixture, or 324
preparation that contains any quantity of a synthetic 325

CS/CS/HB 309 2026

CODING: Words stricken are deletions; words underlined are additions.
hb309-02-c2
Page 14 of 49
F L O R I D A H O U S E O F R E P R E S E N T A T I V E S

cannabinoid found to be in any of the following chemical class 326
descriptions, or homologues, nitrogen-heterocyclic analogs, 327
isomers (including optical, positional, or geometric), esters, 328
ethers, salts, and salts of homologues, nitrogen-heterocyclic 329
analogs, isomers, esters, or ethers, whenever the existence of 330
such homologues, nitrogen-heterocyclic analogs, isomers, esters, 331
ethers, salts, and salts of isomers, esters, or ethers is 332
possible within the specific chemical class or designation. 333
Since nomenclature of these synthetically produced cannabinoids 334
is not internationally standardized and may continually evolve, 335
these structures or the compounds of these structures shall be 336
included under this subparagraph, regardless of their specific 337
numerical designation of atomic positions covered, if it can be 338
determined through a recognized method of scientific testing or 339
analysis that the substance contains properties that fit within 340
one or more of the following categories: 341
a. Tetrahydrocannabinols.—Any tetrahydrocannabinols 342
naturally contained in a plant of the genus Cannabis, the 343
synthetic equivalents of the substances contained in the plant 344
or in the resinous extracts of the genus Cannabis, or synthetic 345
substances, derivatives, and their isomers with similar chemical 346
structure and pharmacological activity, including, but not 347
limited to, Delta 9 tetrahydrocannabinols and their optical 348
isomers, Delta 8 tetrahydrocannabinols and their optical 349
isomers, Delta 6a,10a tetrahydrocannabinols and their optical 350

CS/CS/HB 309 2026

CODING: Words stricken are deletions; words underlined are additions.
hb309-02-c2
Page 15 of 49
F L O R I D A H O U S E O F R E P R E S E N T A T I V E S

isomers, or any compound containing a tetrahydrobenzo[c]chromene 351
structure with substitution at either or both the 3-position or 352
9-position, with or without substitution at the 1-position with 353
hydroxyl or alkoxy groups, including, but not limited to: 354
(I) Tetrahydrocannabinol. 355
(II) HU-210 ((6aR,10aR)-9-(Hydroxymethyl)-6,6-dimethyl-3-356
(2-methyloctan-2-yl)-6a,7,10,10a-tetrahydrobenzo[c]chromen-1-357
ol). 358
(III) HU-211 ((6aS,10aS)-9-(Hydroxymethyl)-6,6-dimethyl-3-359
(2-methyloctan-2-yl)-6a,7,10,10a-tetrahydrobenzo[c]chromen-1-360
ol). 361
(IV) JWH-051 ((6aR,10aR)-9-(Hydroxymethyl)-6,6-dimethyl-3-362
(2-methyloctan-2-yl)-6a,7,10,10a-tetrahydrobenzo[c]chromene). 363
(V) JWH-133 ((6aR,10aR)-6,6,9-Trimethyl-3-(2-methylpentan-364
2-yl)-6a,7,10,10a-tetrahydrobenzo[c]chromene). 365
(VI) JWH-057 ((6aR,10aR)-6,6,9-Trimethyl-3-(2-methyloctan-366
2-yl)-6a,7,10,10a-tetrahydrobenzo[c]chromene). 367
(VII) JWH-359 ((6aR,10aR)-1-Methoxy-6,6,9-trimethyl-3-368
(2,3-dimethylpentan-2-yl)-6a,7,10,10a-369
tetrahydrobenzo[c]chromene). 370
(VIII) AM-087 ((6aR,10aR)-3-(2-Methyl-6-bromohex-2-yl)-371
6,6,9-trimethyl-6a,7,10,10a-tetrahydrobenzo[c]chromen-1-ol). 372
(IX) AM-411 ((6aR,10aR)-3-(1-Adamantyl)-6,6,9-trimethyl-373
6a,7,10,10a-tetrahydrobenzo[c]chromen-1-ol). 374
(X) Parahexyl. 375

CS/CS/HB 309 2026

CODING: Words stricken are deletions; words underlined are additions.
hb309-02-c2
Page 16 of 49
F L O R I D A H O U S E O F R E P R E S E N T A T I V E S

b. Naphthoylindoles, Naphthoylindazoles, 376
Naphthoylcarbazoles, Naphthylmethylindoles, 377
Naphthylmethylindazoles, and Naphthylmethylcarbazoles.—Any 378
compound containing a naphthoylindole, naphthoylindazole, 379
naphthoylcarbazole, naphthylmethylindole, 380
naphthylmethylindazole, or naphthylmethylcarbazole structure, 381
with or without substitution on the indole, indazole, or 382
carbazole ring to any extent, whether or not substituted on the 383
naphthyl ring to any extent, including, but not limited to: 384
(I) JWH-007 (1-Pentyl-2-methyl-3-(1-naphthoyl)indole). 385
(II) JWH-011 (1-(1-Methylhexyl)-2-methyl-3-(1-386
naphthoyl)indole). 387
(III) JWH-015 (1-Propyl-2-methyl-3-(1-naphthoyl)indole). 388
(IV) JWH-016 (1-Butyl-2-methyl-3-(1-naphthoyl)indole). 389
(V) JWH-018 (1-Pentyl-3-(1-naphthoyl)indole). 390
(VI) JWH-019 (1-Hexyl-3-(1-naphthoyl)indole). 391
(VII) JWH-020 (1-Heptyl-3-(1-naphthoyl)indole). 392
(VIII) JWH-022 (1-(4-Pentenyl)-3-(1-naphthoyl)indole). 393
(IX) JWH-071 (1-Ethyl-3-(1-naphthoyl)indole). 394
(X) JWH-072 (1-Propyl-3-(1-naphthoyl)indole). 395
(XI) JWH-073 (1-Butyl-3-(1-naphthoyl)indole). 396
(XII) JWH-080 (1-Butyl-3-(4-methoxy-1-naphthoyl)indole). 397
(XIII) JWH-081 (1-Pentyl-3-(4-methoxy-1-naphthoyl)indole). 398
(XIV) JWH-098 (1-Pentyl-2-methyl-3-(4-methoxy-1-399
naphthoyl)indole). 400

CS/CS/HB 309 2026

CODING: Words stricken are deletions; words underlined are additions.
hb309-02-c2
Page 17 of 49
F L O R I D A H O U S E O F R E P R E S E N T A T I V E S

(XV) JWH-116 (1-Pentyl-2-ethyl-3-(1-naphthoyl)indole). 401
(XVI) JWH-122 (1-Pentyl-3-(4-methyl-1-naphthoyl)indole). 402
(XVII) JWH-149 (1-Pentyl-2-methyl-3-(4-methyl-1-403
naphthoyl)indole). 404
(XVIII) JWH-164 (1-Pentyl-3-(7-methoxy-1-405
naphthoyl)indole). 406
(XIX) JWH-175 (1-Pentyl-3-(1-naphthylmethyl)indole). 407
(XX) JWH-180 (1-Propyl-3-(4-propyl-1-naphthoyl)indole). 408
(XXI) JWH-182 (1-Pentyl-3-(4-propyl-1-naphthoyl)indole). 409
(XXII) JWH-184 (1-Pentyl-3-[(4-methyl)-1-410
naphthylmethyl]indole). 411
(XXIII) JWH-193 (1-[2-(4-Morpholinyl)ethyl]-3-(4-methyl-1-412
naphthoyl)indole). 413
(XXIV) JWH-198 (1-[2-(4-Morpholinyl)ethyl]-3-(4-methoxy-1-414
naphthoyl)indole). 415
(XXV) JWH-200 (1-[2-(4-Morpholinyl)ethyl]-3-(1-416
naphthoyl)indole). 417
(XXVI) JWH-210 (1-Pentyl-3-(4-ethyl-1-naphthoyl)indole). 418
(XXVII) JWH-387 (1-Pentyl-3-(4-bromo-1-naphthoyl)indole). 419
(XXVIII) JWH-398 (1-Pentyl-3-(4-chloro-1-420
naphthoyl)indole). 421
(XXIX) JWH-412 (1-Pentyl-3-(4-fluoro-1-naphthoyl)indole). 422
(XXX) JWH-424 (1-Pentyl-3-(8-bromo-1-naphthoyl)indole). 423
(XXXI) AM-1220 (1-[(1-Methyl-2-piperidinyl)methyl]-3-(1-424
naphthoyl)indole). 425

CS/CS/HB 309 2026

CODING: Words stricken are deletions; words underlined are additions.
hb309-02-c2
Page 18 of 49
F L O R I D A H O U S E O F R E P R E S E N T A T I V E S

(XXXII) AM-1235 (1-(5-Fluoropentyl)-6-nitro-3-(1-426
naphthoyl)indole). 427
(XXXIII) AM-2201 (1-(5-Fluoropentyl)-3-(1-428
naphthoyl)indole). 429
(XXXIV) Chloro JWH-018 (1-(Chloropentyl)-3-(1-430
naphthoyl)indole). 431
(XXXV) Bromo JWH-018 (1-(Bromopentyl)-3-(1-432
naphthoyl)indole). 433
(XXXVI) AM-2232 (1-(4-Cyanobutyl)-3-(1-naphthoyl)indole). 434
(XXXVII) THJ-2201 (1-(5-Fluoropentyl)-3-(1-435
naphthoyl)indazole). 436
(XXXVIII) MAM-2201 (1-(5-Fluoropentyl)-3-(4-methyl-1-437
naphthoyl)indole). 438
(XXXIX) EAM-2201 (1-(5-Fluoropentyl)-3-(4-ethyl-1-439
naphthoyl)indole). 440
(XL) EG-018 (9-Pentyl-3-(1-naphthoyl)carbazole). 441
(XLI) EG-2201 (9-(5-Fluoropentyl)-3-(1-442
naphthoyl)carbazole). 443
c. Naphthoylpyrroles.—Any compound containing a 444
naphthoylpyrrole structure, with or without substitution on the 445
pyrrole ring to any extent, whether or not substituted on the 446
naphthyl ring to any extent, including, but not limited to: 447
(I) JWH-030 (1-Pentyl-3-(1-naphthoyl)pyrrole). 448
(II) JWH-031 (1-Hexyl-3-(1-naphthoyl)pyrrole). 449
(III) JWH-145 (1-Pentyl-5-phenyl-3-(1-naphthoyl)pyrrole). 450

CS/CS/HB 309 2026

CODING: Words stricken are deletions; words underlined are additions.
hb309-02-c2
Page 19 of 49
F L O R I D A H O U S E O F R E P R E S E N T A T I V E S

(IV) JWH-146 (1-Heptyl-5-phenyl-3-(1-naphthoyl)pyrrole). 451
(V) JWH-147 (1-Hexyl-5-phenyl-3-(1-naphthoyl)pyrrole). 452
(VI) JWH-307 (1-Pentyl-5-(2-fluorophenyl)-3-(1-453
naphthoyl)pyrrole). 454
(VII) JWH-309 (1-Pentyl-5-(1-naphthalenyl)-3-(1-455
naphthoyl)pyrrole). 456
(VIII) JWH-368 (1-Pentyl-5-(3-fluorophenyl)-3-(1-457
naphthoyl)pyrrole). 458
(IX) JWH-369 (1-Pentyl-5-(2-chlorophenyl)-3-(1-459
naphthoyl)pyrrole). 460
(X) JWH-370 (1-Pentyl-5-(2-methylphenyl)-3-(1-461
naphthoyl)pyrrole). 462
d. Naphthylmethylenindenes.—Any compound containing a 463
naphthylmethylenindene structure, with or without substitution 464
at the 3-position of the indene ring to any extent, whether or 465
not substituted on the naphthyl ring to any extent, including, 466
but not limited to, JWH-176 (3-Pentyl-1-467
(naphthylmethylene)indene). 468
e. Phenylacetylindoles and Phenylacetylindazoles.—Any 469
compound containing a phenylacetylindole or phenylacetylindazole 470
structure, with or without substitution on the indole or 471
indazole ring to any extent, whether or not substituted on the 472
phenyl ring to any extent, including, but not limited to: 473
(I) JWH-167 (1-Pentyl-3-(phenylacetyl)indole). 474
(II) JWH-201 (1-Pentyl-3-(4-methoxyphenylacetyl)indole). 475

CS/CS/HB 309 2026

CODING: Words stricken are deletions; words underlined are additions.
hb309-02-c2
Page 20 of 49
F L O R I D A H O U S E O F R E P R E S E N T A T I V E S

(III) JWH-203 (1-Pentyl-3-(2-chlorophenylacetyl)indole). 476
(IV) JWH-250 (1-Pentyl-3-(2-methoxyphenylacetyl)indole). 477
(V) JWH-251 (1-Pentyl-3-(2-methylphenylacetyl)indole). 478
(VI) JWH-302 (1-Pentyl-3-(3-methoxyphenylacetyl)indole). 479
(VII) Cannabipiperidiethanone. 480
(VIII) RCS-8 (1-(2-Cyclohexylethyl)-3-(2-481
methoxyphenylacetyl)indole). 482
f. Cyclohexylphenols.—Any compound containing a 483
cyclohexylphenol structure, with or without substitution at the 484
5-position of the phenolic ring to any extent, whether or not 485
substituted on the cyclohexyl ring to any extent, including, but 486
not limited to: 487
(I) CP 47,497 (2-(3-Hydroxycyclohexyl)-5-(2-methyloctan-2-488
yl)phenol). 489
(II) Cannabicyclohexanol (CP 47,497 dimethyloctyl (C8) 490
homologue). 491
(III) CP-55,940 (2-(3-Hydroxy-6-propanol-cyclohexyl)-5-(2-492
methyloctan-2-yl)phenol). 493
g. Benzoylindoles and Benzoylindazoles.—Any compound 494
containing a benzoylindole or benzoylindazole structure, with or 495
without substitution on the indole or indazole ring to any 496
extent, whether or not substituted on the phenyl ring to any 497
extent, including, but not limited to: 498
(I) AM-679 (1-Pentyl-3-(2-iodobenzoyl)indole). 499
(II) AM-694 (1-(5-Fluoropentyl)-3-(2-iodobenzoyl)indole). 500

CS/CS/HB 309 2026

CODING: Words stricken are deletions; words underlined are additions.
hb309-02-c2
Page 21 of 49
F L O R I D A H O U S E O F R E P R E S E N T A T I V E S

(III) AM-1241 (1-[(N-Methyl-2-piperidinyl)methyl]-3-(2-501
iodo-5-nitrobenzoyl)indole). 502
(IV) Pravadoline (1-[2-(4-Morpholinyl)ethyl]-2-methyl-3-503
(4-methoxybenzoyl)indole). 504
(V) AM-2233 (1-[(N-Methyl-2-piperidinyl)methyl]-3-(2-505
iodobenzoyl)indole). 506
(VI) RCS-4 (1-Pentyl-3-(4-methoxybenzoyl)indole). 507
(VII) RCS-4 C4 homologue (1-Butyl-3-(4-508
methoxybenzoyl)indole). 509
(VIII) AM-630 (1-[2-(4-Morpholinyl)ethyl]-2-methyl-6-iodo-510
3-(4-methoxybenzoyl)indole). 511
h. Tetramethylcyclopropanoylindoles and 512
Tetramethylcyclopropanoylindazoles.—Any compound containing a 513
tetramethylcyclopropanoylindole or 514
tetramethylcyclopropanoylindazole structure, with or without 515
substitution on the indole or indazole ring to any extent, 516
whether or not substituted on the tetramethylcyclopropyl group 517
to any extent, including, but not limited to: 518
(I) UR-144 (1-Pentyl-3-(2,2,3,3-519
tetramethylcyclopropanoyl)indole). 520
(II) XLR11 (1-(5-Fluoropentyl)-3-(2,2,3,3-521
tetramethylcyclopropanoyl)indole). 522
(III) Chloro UR-144 (1-(Chloropentyl)-3-(2,2,3,3-523
tetramethylcyclopropanoyl)indole). 524
(IV) A-796,260 (1-[2-(4-Morpholinyl)ethyl]-3-(2,2,3,3-525

CS/CS/HB 309 2026

CODING: Words stricken are deletions; words underlined are additions.
hb309-02-c2
Page 22 of 49
F L O R I D A H O U S E O F R E P R E S E N T A T I V E S

tetramethylcyclopropanoyl)indole). 526
(V) A-834,735 (1-[4-(Tetrahydropyranyl)methyl]-3-(2,2,3,3-527
tetramethylcyclopropanoyl)indole). 528
(VI) M-144 (1-(5-Fluoropentyl)-2-methyl-3-(2,2,3,3-529
tetramethylcyclopropanoyl)indole). 530
(VII) FUB-144 (1-(4-Fluorobenzyl)-3-(2,2,3,3-531
tetramethylcyclopropanoyl)indole). 532
(VIII) FAB-144 (1-(5-Fluoropentyl)-3-(2,2,3,3-533
tetramethylcyclopropanoyl)indazole). 534
(IX) XLR12 (1-(4,4,4-Trifluorobutyl)-3-(2,2,3,3-535
tetramethylcyclopropanoyl)indole). 536
(X) AB-005 (1-[(1-Methyl-2-piperidinyl)methyl]-3-(2,2,3,3-537
tetramethylcyclopropanoyl)indole). 538
i. Adamantoylindoles, Adamantoylindazoles, Adamantylindole 539
carboxamides, and Adamantylindazole carboxamides.—Any compound 540
containing an adamantoyl indole, adamantoyl indazole, adamantyl 541
indole carboxamide, or adamantyl indazole carboxamide structure, 542
with or without substitution on the indole or indazole ring to 543
any extent, whether or not substituted on the adamantyl ring to 544
any extent, including, but not limited to: 545
(I) AKB48 (N-Adamant-1-yl 1-pentylindazole-3-carboxamide). 546
(II) Fluoro AKB48 (N-Adamant-1-yl 1-547
(fluoropentyl)indazole-3-carboxamide). 548
(III) STS-135 (N-Adamant-1-yl 1-(5-fluoropentyl)indole-3-549
carboxamide). 550

CS/CS/HB 309 2026

CODING: Words stricken are deletions; words underlined are additions.
hb309-02-c2
Page 23 of 49
F L O R I D A H O U S E O F R E P R E S E N T A T I V E S

(IV) AM-1248 (1-(1-Methylpiperidine)methyl-3-(1-551
adamantoyl)indole). 552
(V) AB-001 (1-Pentyl-3-(1-adamantoyl)indole). 553
(VI) APICA (N-Adamant-1-yl 1-pentylindole-3-carboxamide). 554
(VII) Fluoro AB-001 (1-(Fluoropentyl)-3-(1-555
adamantoyl)indole). 556
j. Quinolinylindolecarboxylates, 557
Quinolinylindazolecarboxylates, Quinolinylindolecarboxamides, 558
and Quinolinylindazolecarboxamides.—Any compound containing a 559
quinolinylindole carboxylate, quinolinylindazole carboxylate, 560
isoquinolinylindole carboxylate, isoquinolinylindazole 561
carboxylate, quinolinylindole carboxamide, quinolinylindazole 562
carboxamide, isoquinolinylindole carboxamide, or 563
isoquinolinylindazole carboxamide structure, with or without 564
substitution on the indole or indazole ring to any extent, 565
whether or not substituted on the quinoline or isoquinoline ring 566
to any extent, including, but not limited to: 567
(I) PB-22 (8-Quinolinyl 1-pentylindole-3-carboxylate). 568
(II) Fluoro PB-22 (8-Quinolinyl 1-(fluoropentyl)indole-3-569
carboxylate). 570
(III) BB-22 (8-Quinolinyl 1-(cyclohexylmethyl)indole-3-571
carboxylate). 572
(IV) FUB-PB-22 (8-Quinolinyl 1-(4-fluorobenzyl)indole-3-573
carboxylate). 574
(V) NPB-22 (8-Quinolinyl 1-pentylindazole-3-carboxylate). 575

CS/CS/HB 309 2026

CODING: Words stricken are deletions; words underlined are additions.
hb309-02-c2
Page 24 of 49
F L O R I D A H O U S E O F R E P R E S E N T A T I V E S

(VI) Fluoro NPB-22 (8-Quinolinyl 1-(fluoropentyl)indazole-576
3-carboxylate). 577
(VII) FUB-NPB-22 (8-Quinolinyl 1-(4-fluorobenzyl)indazole-578
3-carboxylate). 579
(VIII) THJ (8-Quinolinyl 1-pentylindazole-3-carboxamide). 580
(IX) Fluoro THJ (8-Quinolinyl 1-(fluoropentyl)indazole-3-581
carboxamide). 582
k. Naphthylindolecarboxylates and 583
Naphthylindazolecarboxylates.—Any compound containing a 584
naphthylindole carboxylate or naphthylindazole carboxylate 585
structure, with or without substitution on the indole or 586
indazole ring to any extent, whether or not substituted on the 587
naphthyl ring to any extent, including, but not limited to: 588
(I) NM-2201 (1-Naphthalenyl 1-(5-fluoropentyl)indole-3-589
carboxylate). 590
(II) SDB-005 (1-Naphthalenyl 1-pentylindazole-3-591
carboxylate). 592
(III) Fluoro SDB-005 (1-Naphthalenyl 1-593
(fluoropentyl)indazole-3-carboxylate). 594
(IV) FDU-PB-22 (1-Naphthalenyl 1-(4-fluorobenzyl)indole-3-595
carboxylate). 596
(V) 3-CAF (2-Naphthalenyl 1-(2-fluorophenyl)indazole-3-597
carboxylate). 598
l. Naphthylindole carboxamides and Naphthylindazole 599
carboxamides.—Any compound containing a naphthylindole 600

CS/CS/HB 309 2026

CODING: Words stricken are deletions; words underlined are additions.
hb309-02-c2
Page 25 of 49
F L O R I D A H O U S E O F R E P R E S E N T A T I V E S

carboxamide or naphthylindazole carboxamide structure, with or 601
without substitution on the indole or indazole ring to any 602
extent, whether or not substituted on the naphthyl ring to any 603
extent, including, but not limited to: 604
(I) NNEI (N-Naphthalen-1-yl 1-pentylindole-3-carboxamide). 605
(II) Fluoro-NNEI (N-Naphthalen-1-yl 1-606
(fluoropentyl)indole-3-carboxamide). 607
(III) Chloro-NNEI (N-Naphthalen-1-yl 1-608
(chloropentyl)indole-3-carboxamide). 609
(IV) MN-18 (N-Naphthalen-1-yl 1-pentylindazole-3-610
carboxamide). 611
(V) Fluoro MN-18 (N-Naphthalen-1-yl 1-612
(fluoropentyl)indazole-3-carboxamide). 613
m. Alkylcarbonyl indole carboxamides, Alkylcarbonyl 614
indazole carboxamides, Alkylcarbonyl indole carboxylates, and 615
Alkylcarbonyl indazole carboxylates.—Any compound containing an 616
alkylcarbonyl group, including 1-amino-3-methyl-1-oxobutan-2-yl, 617
1-methoxy-3-methyl-1-oxobutan-2-yl, 1-amino-1-oxo-3-618
phenylpropan-2-yl, 1-methoxy-1-oxo-3-phenylpropan-2-yl, with an 619
indole carboxamide, indazole carboxamide, indole carboxylate, or 620
indazole carboxylate, with or without substitution on the indole 621
or indazole ring to any extent, whether or not substituted on 622
the alkylcarbonyl group to any extent, including, but not 623
limited to: 624
(I) ADBICA, (N-(1-Amino-3,3-dimethyl-1-oxobutan-2-yl)-1-625

CS/CS/HB 309 2026

CODING: Words stricken are deletions; words underlined are additions.
hb309-02-c2
Page 26 of 49
F L O R I D A H O U S E O F R E P R E S E N T A T I V E S

pentylindole-3-carboxamide). 626
(II) Fluoro ADBICA (N-(1-Amino-3,3-dimethyl-1-oxobutan-2-627
yl)-1-(fluoropentyl)indole-3-carboxamide). 628
(III) Fluoro ABICA (N-(1-Amino-3-methyl-1-oxobutan-2-yl)-629
1-(fluoropentyl)indole-3-carboxamide). 630
(IV) AB-PINACA (N-(1-Amino-3-methyl-1-oxobutan-2-yl)-1-631
pentylindazole-3-carboxamide). 632
(V) Fluoro AB-PINACA (N-(1-Amino-3-methyl-1-oxobutan-2-633
yl)-1-(fluoropentyl)indazole-3-carboxamide). 634
(VI) ADB-PINACA (N-(1-Amino-3,3-dimethyl-1-oxobutan-2-yl)-635
1-pentylindazole-3-carboxamide). 636
(VII) Fluoro ADB-PINACA (N-(1-Amino-3,3-dimethyl-1-637
oxobutan-2-yl)-1-(fluoropentyl)indazole-3-carboxamide). 638
(VIII) AB-FUBINACA (N-(1-Amino-3-methyl-1-oxobutan-2-yl)-639
1-(4-fluorobenzyl)indazole-3-carboxamide). 640
(IX) ADB-FUBINACA (N-(1-Amino-3,3-dimethyl-1-oxobutan-2-641
yl)-1-(4-fluorobenzyl)indazole-3-carboxamide). 642
(X) AB-CHMINACA (N-(1-Amino-3-methyl-1-oxobutan-2-yl)-1-643
(cyclohexylmethyl)indazole-3-carboxamide). 644
(XI) MA-CHMINACA (N-(1-Methoxy-3-methyl-1-oxobutan-2-yl)-645
1-(cyclohexylmethyl)indazole-3-carboxamide). 646
(XII) MAB-CHMINACA (N-(1-Amino-3,3-dimethyl-1-oxobutan-2-647
yl)-1-(cyclohexylmethyl)indazole-3-carboxamide). 648
(XIII) AMB (N-(1-Methoxy-3-methyl-1-oxobutan-2-yl)-1-649
pentylindazole-3-carboxamide). 650

CS/CS/HB 309 2026

CODING: Words stricken are deletions; words underlined are additions.
hb309-02-c2
Page 27 of 49
F L O R I D A H O U S E O F R E P R E S E N T A T I V E S

(XIV) Fluoro-AMB (N-(1-Methoxy-3-methyl-1-oxobutan-2-yl)-651
1-(fluoropentyl)indazole-3-carboxamide). 652
(XV) FUB-AMB (N-(1-Methoxy-3-methyl-1-oxobutan-2-yl)-1-(4-653
fluorobenzyl)indazole-3-carboxamide). 654
(XVI) MDMB-CHMINACA (N-(1-Methoxy-3,3-dimethyl-1-oxobutan-655
2-yl)-1-(cyclohexylmethyl)indazole-3-carboxamide). 656
(XVII) MDMB-FUBINACA (N-(1-Methoxy-3,3-dimethyl-1-657
oxobutan-2-yl)-1-(4-fluorobenzyl)indazole-3-carboxamide). 658
(XVIII) MDMB-CHMICA (N-(1-Methoxy-3,3-dimethyl-1-oxobutan-659
2-yl)-1-(cyclohexylmethyl)indole-3-carboxamide). 660
(XIX) PX-1 (N-(1-Amino-1-oxo-3-phenylpropan-2-yl)-1-(5-661
fluoropentyl)indole-3-carboxamide). 662
(XX) PX-2 (N-(1-Amino-1-oxo-3-phenylpropan-2-yl)-1-(5-663
fluoropentyl)indazole-3-carboxamide). 664
(XXI) PX-3 (N-(1-Amino-1-oxo-3-phenylpropan-2-yl)-1-665
(cyclohexylmethyl)indazole-3-carboxamide). 666
(XXII) PX-4 (N-(1-Amino-1-oxo-3-phenylpropan-2-yl)-1-(4-667
fluorobenzyl)indazole-3-carboxamide). 668
(XXIII) MO-CHMINACA (N-(1-Methoxy-3,3-dimethyl-1-oxobutan-669
2-yl)-1-(cyclohexylmethyl)indazole-3-carboxylate). 670
n. Cumylindolecarboxamides and Cumylindazolecarboxamides.—671
Any compound containing a N-(2-phenylpropan-2-yl) indole 672
carboxamide or N-(2-phenylpropan-2-yl) indazole carboxamide 673
structure, with or without substitution on the indole or 674
indazole ring to any extent, whether or not substituted on the 675

CS/CS/HB 309 2026

CODING: Words stricken are deletions; words underlined are additions.
hb309-02-c2
Page 28 of 49
F L O R I D A H O U S E O F R E P R E S E N T A T I V E S

phenyl ring of the cumyl group to any extent, including, but not 676
limited to: 677
(I) CUMYL-PICA (N-(2-Phenylpropan-2-yl)-1-pentylindole-3-678
carboxamide). 679
(II) Fluoro CUMYL-PICA (N-(2-Phenylpropan-2-yl)-1-680
(fluoropentyl)indole-3-carboxamide). 681
o. Other Synthetic Cannabinoids.—Any material, compound, 682
mixture, or preparation that contains any quantity of a 683
Synthetic Cannabinoid, as described in sub-subparagraphs a.-n.: 684
(I) With or without modification or replacement of a 685
carbonyl, carboxamide, alkylene, alkyl, or carboxylate linkage 686
between either two core rings, or linkage between a core ring 687
and group structure, with or without the addition of a carbon or 688
replacement of a carbon; 689
(II) With or without replacement of a core ring or group 690
structure, whether or not substituted on the ring or group 691
structures to any extent; and 692
(III) Is a cannabinoid receptor agonist, unless 693
specifically excepted or unless listed in another schedule or 694
contained within a pharmaceutical product approved by the United 695
States Food and Drug Administration. 696
191. Substituted Cathinones.—Unless specifically excepted, 697
listed in another schedule, or contained within a pharmaceutical 698
product approved by the United States Food and Drug 699
Administration, any material, compound, mixture, or preparation, 700

CS/CS/HB 309 2026

CODING: Words stricken are deletions; words underlined are additions.
hb309-02-c2
Page 29 of 49
F L O R I D A H O U S E O F R E P R E S E N T A T I V E S

including its salts, isomers, esters, or ethers, and salts of 701
isomers, esters, or ethers, whenever the existence of such salts 702
is possible within any of the following specific chemical 703
designations: 704
a. Any compound containing a 2-amino-1-phenyl-1-propanone 705
structure; 706
b. Any compound containing a 2-amino-1-naphthyl-1-707
propanone structure; or 708
c. Any compound containing a 2-amino-1-thiophenyl-1-709
propanone structure, whether or not the compound is further 710
modified: 711
(I) With or without substitution on the ring system to any 712
extent with alkyl, alkylthio, thio, fused alkylenedioxy, alkoxy, 713
haloalkyl, hydroxyl, nitro, fused furan, fused benzofuran, fused 714
dihydrofuran, fused tetrahydropyran, fused alkyl ring, or halide 715
substituents; 716
(II) With or without substitution at the 3-propanone 717
position with an alkyl substituent or removal of the methyl 718
group at the 3-propanone position; 719
(III) With or without substitution at the 2-amino nitrogen 720
atom with alkyl, dialkyl, acetyl, or benzyl groups, whether or 721
not further substituted in the ring system; or 722
(IV) With or without inclusion of the 2-amino nitrogen 723
atom in a cyclic structure, including, but not limited to: 724
(A) Methcathinone. 725

CS/CS/HB 309 2026

CODING: Words stricken are deletions; words underlined are additions.
hb309-02-c2
Page 30 of 49
F L O R I D A H O U S E O F R E P R E S E N T A T I V E S

(B) Ethcathinone. 726
(C) Methylone (3,4-Methylenedioxymethcathinone). 727
(D) 2,3-Methylenedioxymethcathinone. 728
(E) MDPV (3,4-Methylenedioxypyrovalerone). 729
(F) Methylmethcathinone. 730
(G) Methoxymethcathinone. 731
(H) Fluoromethcathinone. 732
(I) Methylethcathinone. 733
(J) Butylone (3,4-Methylenedioxy-alpha-734
methylaminobutyrophenone). 735
(K) Ethylone (3,4-Methylenedioxy-N-ethylcathinone). 736
(L) BMDP (3,4-Methylenedioxy-N-benzylcathinone). 737
(M) Naphyrone (Naphthylpyrovalerone). 738
(N) Bromomethcathinone. 739
(O) Buphedrone (alpha-Methylaminobutyrophenone). 740
(P) Eutylone (3,4-Methylenedioxy-alpha-741
ethylaminobutyrophenone). 742
(Q) Dimethylcathinone. 743
(R) Dimethylmethcathinone. 744
(S) Pentylone (3,4-Methylenedioxy-alpha-745
methylaminovalerophenone). 746
(T) Pentedrone (alpha-Methylaminovalerophenone). 747
(U) MDPPP (3,4-Methylenedioxy-alpha-748
pyrrolidinopropiophenone). 749
(V) MDPBP (3,4-Methylenedioxy-alpha-750

CS/CS/HB 309 2026

CODING: Words stricken are deletions; words underlined are additions.
hb309-02-c2
Page 31 of 49
F L O R I D A H O U S E O F R E P R E S E N T A T I V E S

pyrrolidinobutyrophenone). 751
(W) MPPP (Methyl-alpha-pyrrolidinopropiophenone). 752
(X) PPP (Pyrrolidinopropiophenone). 753
(Y) PVP (Pyrrolidinovalerophenone) or 754
(Pyrrolidinopentiophenone). 755
(Z) MOPPP (Methoxy-alpha-pyrrolidinopropiophenone). 756
(AA) MPHP (Methyl-alpha-pyrrolidinohexanophenone). 757
(BB) F-MABP (Fluoromethylaminobutyrophenone). 758
(CC) Me-EABP (Methylethylaminobutyrophenone). 759
(DD) PBP (Pyrrolidinobutyrophenone). 760
(EE) MeO-PBP (Methoxypyrrolidinobutyrophenone). 761
(FF) Et-PBP (Ethylpyrrolidinobutyrophenone). 762
(GG) 3-Me-4-MeO-MCAT (3-Methyl-4-Methoxymethcathinone). 763
(HH) Dimethylone (3,4-Methylenedioxy-N,N-764
dimethylcathinone). 765
(II) 3,4-Methylenedioxy-N,N-diethylcathinone. 766
(JJ) 3,4-Methylenedioxy-N-acetylcathinone. 767
(KK) 3,4-Methylenedioxy-N-acetylmethcathinone. 768
(LL) 3,4-Methylenedioxy-N-acetylethcathinone. 769
(MM) Methylbuphedrone (Methyl-alpha-770
methylaminobutyrophenone). 771
(NN) Methyl-alpha-methylaminohexanophenone. 772
(OO) N-Ethyl-N-methylcathinone. 773
(PP) PHP (Pyrrolidinohexanophenone). 774
(QQ) PV8 (Pyrrolidinoheptanophenone). 775

CS/CS/HB 309 2026

CODING: Words stricken are deletions; words underlined are additions.
hb309-02-c2
Page 32 of 49
F L O R I D A H O U S E O F R E P R E S E N T A T I V E S

(RR) Chloromethcathinone. 776
(SS) 4-Bromo-2,5-dimethoxy-alpha-aminoacetophenone. 777
192. Substituted Phenethylamines.—Unless specifically 778
excepted or unless listed in another schedule, or contained 779
within a pharmaceutical product approved by the United States 780
Food and Drug Administration, any material, compound, mixture, 781
or preparation, including its salts, isomers, esters, or ethers, 782
and salts of isomers, esters, or ethers, whenever the existence 783
of such salts is possible within any of the following specific 784
chemical designations, any compound containing a phenethylamine 785
structure, without a beta-keto group, and without a benzyl group 786
attached to the amine group, whether or not the compound is 787
further modified with or without substitution on the phenyl ring 788
to any extent with alkyl, alkylthio, nitro, alkoxy, thio, 789
halide, fused alkylenedioxy, fused furan, fused benzofuran, 790
fused dihydrofuran, or fused tetrahydropyran substituents, 791
whether or not further substituted on a ring to any extent, with 792
or without substitution at the alpha or beta position by any 793
alkyl substituent, with or without substitution at the nitrogen 794
atom, and with or without inclusion of the 2-amino nitrogen atom 795
in a cyclic structure, including, but not limited to: 796
a. 2C-B (4-Bromo-2,5-dimethoxyphenethylamine). 797
b. 2C-E (4-Ethyl-2,5-dimethoxyphenethylamine). 798
c. 2C-T-4 (4-Isopropylthio-2,5-dimethoxyphenethylamine). 799
d. 2C-C (4-Chloro-2,5-dimethoxyphenethylamine). 800

CS/CS/HB 309 2026

CODING: Words stricken are deletions; words underlined are additions.
hb309-02-c2
Page 33 of 49
F L O R I D A H O U S E O F R E P R E S E N T A T I V E S

e. 2C-T (4-Methylthio-2,5-dimethoxyphenethylamine). 801
f. 2C-T-2 (4-Ethylthio-2,5-dimethoxyphenethylamine). 802
g. 2C-T-7 (4-(n)-Propylthio-2,5-dimethoxyphenethylamine). 803
h. 2C-I (4-Iodo-2,5-dimethoxyphenethylamine). 804
i. 2C-D (4-Methyl-2,5-dimethoxyphenethylamine). 805
j. 2C-H (2,5-Dimethoxyphenethylamine). 806
k. 2C-N (4-Nitro-2,5-dimethoxyphenethylamine). 807
l. 2C-P (4-(n)-Propyl-2,5-dimethoxyphenethylamine). 808
m. MDMA (3,4-Methylenedioxymethamphetamine). 809
n. MBDB (Methylbenzodioxolylbutanamine) or (3,4-810
Methylenedioxy-N-methylbutanamine). 811
o. MDA (3,4-Methylenedioxyamphetamine). 812
p. 2,5-Dimethoxyamphetamine. 813
q. Fluoroamphetamine. 814
r. Fluoromethamphetamine. 815
s. MDEA (3,4-Methylenedioxy-N-ethylamphetamine). 816
t. DOB (4-Bromo-2,5-dimethoxyamphetamine). 817
u. DOC (4-Chloro-2,5-dimethoxyamphetamine). 818
v. DOET (4-Ethyl-2,5-dimethoxyamphetamine). 819
w. DOI (4-Iodo-2,5-dimethoxyamphetamine). 820
x. DOM (4-Methyl-2,5-dimethoxyamphetamine). 821
y. PMA (4-Methoxyamphetamine). 822
z. N-Ethylamphetamine. 823
aa. 3,4-Methylenedioxy-N-hydroxyamphetamine. 824
bb. 5-Methoxy-3,4-methylenedioxyamphetamine. 825

CS/CS/HB 309 2026

CODING: Words stricken are deletions; words underlined are additions.
hb309-02-c2
Page 34 of 49
F L O R I D A H O U S E O F R E P R E S E N T A T I V E S

cc. PMMA (4-Methoxymethamphetamine). 826
dd. N,N-Dimethylamphetamine. 827
ee. 3,4,5-Trimethoxyamphetamine. 828
ff. 4-APB (4-(2-Aminopropyl)benzofuran). 829
gg. 5-APB (5-(2-Aminopropyl)benzofuran). 830
hh. 6-APB (6-(2-Aminopropyl)benzofuran). 831
ii. 7-APB (7-(2-Aminopropyl)benzofuran). 832
jj. 4-APDB (4-(2-Aminopropyl)-2,3-dihydrobenzofuran). 833
kk. 5-APDB (5-(2-Aminopropyl)-2,3-dihydrobenzofuran). 834
ll. 6-APDB (6-(2-Aminopropyl)-2,3-dihydrobenzofuran). 835
mm. 7-APDB (7-(2-Aminopropyl)-2,3-dihydrobenzofuran). 836
nn. 4-MAPB (4-(2-Methylaminopropyl)benzofuran). 837
oo. 5-MAPB (5-(2-Methylaminopropyl)benzofuran). 838
pp. 6-MAPB (6-(2-Methylaminopropyl)benzofuran). 839
qq. 7-MAPB (7-(2-Methylaminopropyl)benzofuran). 840
rr. 5-EAPB (5-(2-Ethylaminopropyl)benzofuran). 841
ss. 5-MAPDB (5-(2-Methylaminopropyl)-2,3-842
dihydrobenzofuran), 843
844
which does not include phenethylamine, mescaline as described in 845
subparagraph 20., substituted cathinones as described in 846
subparagraph 191., N-Benzyl phenethylamine compounds as 847
described in subparagraph 193., or methamphetamine as described 848
in subparagraph (2)(c)5. 849
193. N-Benzyl Phenethylamine Compounds.—Unless 850

CS/CS/HB 309 2026

CODING: Words stricken are deletions; words underlined are additions.
hb309-02-c2
Page 35 of 49
F L O R I D A H O U S E O F R E P R E S E N T A T I V E S

specifically excepted or unless listed in another schedule, or 851
contained within a pharmaceutical product approved by the United 852
States Food and Drug Administration, any material, compound, 853
mixture, or preparation, including its salts, isomers, esters, 854
or ethers, and salts of isomers, esters, or ethers, whenever the 855
existence of such salts is possible within any of the following 856
specific chemical designations, any compound containing a 857
phenethylamine structure without a beta-keto group, with 858
substitution on the nitrogen atom of the amino group with a 859
benzyl substituent, with or without substitution on the phenyl 860
or benzyl ring to any extent with alkyl, alkoxy, thio, 861
alkylthio, halide, fused alkylenedioxy, fused furan, fused 862
benzofuran, or fused tetrahydropyran substituents, whether or 863
not further substituted on a ring to any extent, with or without 864
substitution at the alpha position by any alkyl substituent, 865
including, but not limited to: 866
a. 25B-NBOMe (4-Bromo-2,5-dimethoxy-[N-(2-867
methoxybenzyl)]phenethylamine). 868
b. 25B-NBOH (4-Bromo-2,5-dimethoxy-[N-(2-869
hydroxybenzyl)]phenethylamine). 870
c. 25B-NBF (4-Bromo-2,5-dimethoxy-[N-(2-871
fluorobenzyl)]phenethylamine). 872
d. 25B-NBMD (4-Bromo-2,5-dimethoxy-[N-(2,3-873
methylenedioxybenzyl)]phenethylamine). 874
e. 25I-NBOMe (4-Iodo-2,5-dimethoxy-[N-(2-875

CS/CS/HB 309 2026

CODING: Words stricken are deletions; words underlined are additions.
hb309-02-c2
Page 36 of 49
F L O R I D A H O U S E O F R E P R E S E N T A T I V E S

methoxybenzyl)]phenethylamine). 876
f. 25I-NBOH (4-Iodo-2,5-dimethoxy-[N-(2-877
hydroxybenzyl)]phenethylamine). 878
g. 25I-NBF (4-Iodo-2,5-dimethoxy-[N-(2-879
fluorobenzyl)]phenethylamine). 880
h. 25I-NBMD (4-Iodo-2,5-dimethoxy-[N-(2,3-881
methylenedioxybenzyl)]phenethylamine). 882
i. 25T2-NBOMe (4-Methylthio-2,5-dimethoxy-[N-(2-883
methoxybenzyl)]phenethylamine). 884
j. 25T4-NBOMe (4-Isopropylthio-2,5-dimethoxy-[N-(2-885
methoxybenzyl)]phenethylamine). 886
k. 25T7-NBOMe (4-(n)-Propylthio-2,5-dimethoxy-[N-(2-887
methoxybenzyl)]phenethylamine). 888
l. 25C-NBOMe (4-Chloro-2,5-dimethoxy-[N-(2-889
methoxybenzyl)]phenethylamine). 890
m. 25C-NBOH (4-Chloro-2,5-dimethoxy-[N-(2-891
hydroxybenzyl)]phenethylamine). 892
n. 25C-NBF (4-Chloro-2,5-dimethoxy-[N-(2-893
fluorobenzyl)]phenethylamine). 894
o. 25C-NBMD (4-Chloro-2,5-dimethoxy-[N-(2,3-895
methylenedioxybenzyl)]phenethylamine). 896
p. 25H-NBOMe (2,5-Dimethoxy-[N-(2-897
methoxybenzyl)]phenethylamine). 898
q. 25H-NBOH (2,5-Dimethoxy-[N-(2-899
hydroxybenzyl)]phenethylamine). 900

CS/CS/HB 309 2026

CODING: Words stricken are deletions; words underlined are additions.
hb309-02-c2
Page 37 of 49
F L O R I D A H O U S E O F R E P R E S E N T A T I V E S

r. 25H-NBF (2,5-Dimethoxy-[N-(2-901
fluorobenzyl)]phenethylamine). 902
s. 25D-NBOMe (4-Methyl-2,5-dimethoxy-[N-(2-903
methoxybenzyl)]phenethylamine), 904
905
which does not include substituted cathinones as described in 906
subparagraph 191. 907
194. Substituted Tryptamines.—Unless specifically excepted 908
or unless listed in another schedule, or contained within a 909
pharmaceutical product approved by the United States Food and 910
Drug Administration, any material, compound, mixture, or 911
preparation containing a 2-(1H-indol-3-yl)ethanamine, for 912
example tryptamine, structure with or without mono- or di-913
substitution of the amine nitrogen with alkyl or alkenyl groups, 914
or by inclusion of the amino nitrogen atom in a cyclic 915
structure, whether or not substituted at the alpha position with 916
an alkyl group, whether or not substituted on the indole ring to 917
any extent with any alkyl, alkoxy, halo, hydroxyl, or acetoxy 918
groups, including, but not limited to: 919
a. Alpha-Ethyltryptamine. 920
b. Bufotenine. 921
c. DET (Diethyltryptamine). 922
d. DMT (Dimethyltryptamine). 923
e. MET (N-Methyl-N-ethyltryptamine). 924
f. DALT (N,N-Diallyltryptamine). 925

CS/CS/HB 309 2026

CODING: Words stricken are deletions; words underlined are additions.
hb309-02-c2
Page 38 of 49
F L O R I D A H O U S E O F R E P R E S E N T A T I V E S

g. EiPT (N-Ethyl-N-isopropyltryptamine). 926
h. MiPT (N-Methyl-N-isopropyltryptamine). 927
i. 5-Hydroxy-AMT (5-Hydroxy-alpha-methyltryptamine). 928
j. 5-Hydroxy-N-methyltryptamine. 929
k. 5-MeO-MiPT (5-Methoxy-N-methyl-N-isopropyltryptamine). 930
l. 5-MeO-AMT (5-Methoxy-alpha-methyltryptamine). 931
m. Methyltryptamine. 932
n. 5-MeO-DMT (5-Methoxy-N,N-dimethyltryptamine). 933
o. 5-Me-DMT (5-Methyl-N,N-dimethyltryptamine). 934
p. 5-MeO-DiPT (5-Methoxy-N,N-Diisopropyltryptamine). 935
q. DiPT (N,N-Diisopropyltryptamine). 936
r. DPT (N,N-Dipropyltryptamine). 937
s. 4-Hydroxy-DiPT (4-Hydroxy-N,N-diisopropyltryptamine). 938
t. 5-MeO-DALT (5-Methoxy-N,N-Diallyltryptamine). 939
u. 4-AcO-DMT (4-Acetoxy-N,N-dimethyltryptamine). 940
v. 4-AcO-DiPT (4-Acetoxy-N,N-diisopropyltryptamine). 941
w. 4-Hydroxy-DET (4-Hydroxy-N,N-diethyltryptamine). 942
x. 4-Hydroxy-MET (4-Hydroxy-N-methyl-N-ethyltryptamine). 943
y. 4-Hydroxy-MiPT (4-Hydroxy-N-methyl-N-944
isopropyltryptamine). 945
z. Methyl-alpha-ethyltryptamine. 946
aa. Bromo-DALT (Bromo-N,N-diallyltryptamine), 947
948
which does not include tryptamine, psilocyn as described in 949
subparagraph 34., or psilocybin as described in subparagraph 33. 950

CS/CS/HB 309 2026

CODING: Words stricken are deletions; words underlined are additions.
hb309-02-c2
Page 39 of 49
F L O R I D A H O U S E O F R E P R E S E N T A T I V E S

195. Substituted Phenylcyclohexylamines.—Unless 951
specifically excepted or unless listed in another schedule, or 952
contained within a pharmaceutical product approved by the United 953
States Food and Drug Administration, any material, compound, 954
mixture, or preparation containing a phenylcyclohexylamine 955
structure, with or without any substitution on the phenyl ring, 956
any substitution on the cyclohexyl ring, any replacement of the 957
phenyl ring with a thiophenyl or benzothiophenyl ring, with or 958
without substitution on the amine with alkyl, dialkyl, or alkoxy 959
substituents, inclusion of the nitrogen in a cyclic structure, 960
or any combination of the above, including, but not limited to: 961
a. BTCP (Benzothiophenylcyclohexylpiperidine) or BCP 962
(Benocyclidine). 963
b. PCE (N-Ethyl-1-phenylcyclohexylamine)(Ethylamine analog 964
of phencyclidine). 965
c. PCPY (N-(1-Phenylcyclohexyl)-pyrrolidine)(Pyrrolidine 966
analog of phencyclidine). 967
d. PCPr (Phenylcyclohexylpropylamine). 968
e. TCP (1-[1-(2-Thienyl)-cyclohexyl]-piperidine)(Thiophene 969
analog of phencyclidine). 970
f. PCEEA (Phenylcyclohexyl(ethoxyethylamine)). 971
g. PCMPA (Phenylcyclohexyl(methoxypropylamine)). 972
h. Methoxetamine. 973
i. 3-Methoxy-PCE ((3-Methoxyphenyl)cyclohexylethylamine). 974
j. Bromo-PCP ((Bromophenyl)cyclohexylpiperidine). 975

CS/CS/HB 309 2026

CODING: Words stricken are deletions; words underlined are additions.
hb309-02-c2
Page 40 of 49
F L O R I D A H O U S E O F R E P R E S E N T A T I V E S

k. Chloro-PCP ((Chlorophenyl)cyclohexylpiperidine). 976
l. Fluoro-PCP ((Fluorophenyl)cyclohexylpiperidine). 977
m. Hydroxy-PCP ((Hydroxyphenyl)cyclohexylpiperidine). 978
n. Methoxy-PCP ((Methoxyphenyl)cyclohexylpiperidine). 979
o. Methyl-PCP ((Methylphenyl)cyclohexylpiperidine). 980
p. Nitro-PCP ((Nitrophenyl)cyclohexylpiperidine). 981
q. Oxo-PCP ((Oxophenyl)cyclohexylpiperidine). 982
r. Amino-PCP ((Aminophenyl)cyclohexylpiperidine). 983
196. W-15, 4-chloro-N-[1-(2-phenylethyl)-2-984
piperidinylidene]-benzenesulfonamide. 985
197. W-18, 4-chloro-N-[1-[2-(4-nitrophenyl)ethyl]-2-986
piperidinylidene]-benzenesulfonamide. 987
198. AH-7921, 3,4-dichloro-N-[[1-988
(dimethylamino)cyclohexyl]methyl]-benzamide. 989
199. U47700, trans-3,4-dichloro-N-[2-990
(dimethylamino)cyclohexyl]-N-methyl-benzamide. 991
200. MT-45, 1-cyclohexyl-4-(1,2-diphenylethyl)-piperazine, 992
dihydrochloride. 993
Section 2. Paragraph (i) of subsection (1) of section 994
893.13, Florida Statutes, is amended to read: 995
893.13 Prohibited acts; penalties.— 996
(1) 997
(i) Except as authorized by this chapter, a person commits 998
a felony of the first degree, punishable as provided in s. 999
775.082, s. 775.083, or s. 775.084, and must be sentenced to a 1000

CS/CS/HB 309 2026

CODING: Words stricken are deletions; words underlined are additions.
hb309-02-c2
Page 41 of 49
F L O R I D A H O U S E O F R E P R E S E N T A T I V E S

mandatory minimum term of imprisonment of 3 years, if: 1001
1. The person sells, manufactures, or delivers, or 1002
possesses with intent to sell, manufacture, or deliver, any of 1003
the following: 1004
a. Alfentanil, as described in s. 893.03(2)(b)1.; 1005
b. Carfentanil, as described in s. 893.03(2)(b)6.; 1006
c. Fentanyl, as described in s. 893.03(2)(b)9.; 1007
d. Sufentanil, as described in s. 893.03(2)(b)30.; 1008
e. A fentanyl derivative, as described in s. 1009
893.03(1)(a)63.; 1010
f. Xylazine, as described in s. 893.03(1)(c)37.; 1011
g.f. A controlled substance analog, as described in s. 1012
893.0356, of any substance described in sub-subparagraphs a.-f. 1013
sub-subparagraphs a.-e.; or 1014
h.g. A mixture containing any substance described in sub-1015
subparagraphs a.-g. sub-subparagraphs a.-f.; and 1016
2. The substance or mixture listed in subparagraph 1. is 1017
in a form that resembles, or is mixed, granulated, absorbed, 1018
spray-dried, or aerosolized as or onto, coated on, in whole or 1019
in part, or solubilized with or into, a product, when such 1020
product or its packaging further has at least one of the 1021
following attributes: 1022
a. Resembles the trade dress of a branded food product, 1023
consumer food product, or logo food product; 1024
b. Incorporates an actual or fake registered copyright, 1025

CS/CS/HB 309 2026

CODING: Words stricken are deletions; words underlined are additions.
hb309-02-c2
Page 42 of 49
F L O R I D A H O U S E O F R E P R E S E N T A T I V E S

service mark, or trademark; 1026
c. Resembles candy, cereal, a gummy, a vitamin, or a 1027
chewable product, such as a gum or gelatin-based product; or 1028
d. Contains a cartoon character imprint. 1029
Section 3. Paragraph (c) of subsection (1) of section 1030
893.135, Florida Statutes, is amended to read: 1031
893.135 Trafficking; mandatory sentences; suspension or 1032
reduction of sentences; conspiracy to engage in trafficking.— 1033
(1) Except as authorized in this chapter or in chapter 499 1034
and notwithstanding the provisions of s. 893.13: 1035
(c)1. A person who knowingly sells, purchases, 1036
manufactures, delivers, or brings into this state, or who is 1037
knowingly in actual or constructive possession of, 4 grams or 1038
more of any morphine, opium, hydromorphone, or any salt, 1039
derivative, isomer, or salt of an isomer thereof, including 1040
heroin, as described in s. 893.03(1)(b), (2)(a), (3)(c)3., or 1041
(3)(c)4., or 4 grams or more of any mixture containing any such 1042
substance, but less than 30 kilograms of such substance or 1043
mixture, commits a felony of the first degree, which felony 1044
shall be known as "trafficking in illegal drugs," punishable as 1045
provided in s. 775.082, s. 775.083, or s. 775.084. If the 1046
quantity involved: 1047
a. Is 4 grams or more, but less than 14 grams, such person 1048
shall be sentenced to a mandatory minimum term of imprisonment 1049
of 3 years and shall be ordered to pay a fine of $50,000. 1050

CS/CS/HB 309 2026

CODING: Words stricken are deletions; words underlined are additions.
hb309-02-c2
Page 43 of 49
F L O R I D A H O U S E O F R E P R E S E N T A T I V E S

b. Is 14 grams or more, but less than 28 grams, such 1051
person shall be sentenced to a mandatory minimum term of 1052
imprisonment of 15 years and shall be ordered to pay a fine of 1053
$100,000. 1054
c. Is 28 grams or more, but less than 30 kilograms, such 1055
person shall be sentenced to a mandatory minimum term of 1056
imprisonment of 25 years and shall be ordered to pay a fine of 1057
$500,000. 1058
2. A person who knowingly sells, purchases, manufactures, 1059
delivers, or brings into this state, or who is knowingly in 1060
actual or constructive possession of, 28 grams or more of 1061
hydrocodone, as described in s. 893.03(2)(a)1.k., codeine, as 1062
described in s. 893.03(2)(a)1.g., or any salt thereof, or 28 1063
grams or more of any mixture containing any such substance, 1064
commits a felony of the first degree, which felony shall be 1065
known as "trafficking in hydrocodone," punishable as provided in 1066
s. 775.082, s. 775.083, or s. 775.084. If the quantity involved: 1067
a. Is 28 grams or more, but less than 50 grams, such 1068
person shall be sentenced to a mandatory minimum term of 1069
imprisonment of 3 years and shall be ordered to pay a fine of 1070
$50,000. 1071
b. Is 50 grams or more, but less than 100 grams, such 1072
person shall be sentenced to a mandatory minimum term of 1073
imprisonment of 7 years and shall be ordered to pay a fine of 1074
$100,000. 1075

CS/CS/HB 309 2026

CODING: Words stricken are deletions; words underlined are additions.
hb309-02-c2
Page 44 of 49
F L O R I D A H O U S E O F R E P R E S E N T A T I V E S

c. Is 100 grams or more, but less than 300 grams, such 1076
person shall be sentenced to a mandatory minimum term of 1077
imprisonment of 15 years and shall be ordered to pay a fine of 1078
$500,000. 1079
d. Is 300 grams or more, but less than 30 kilograms, such 1080
person shall be sentenced to a mandatory minimum term of 1081
imprisonment of 25 years and shall be ordered to pay a fine of 1082
$750,000. 1083
3. A person who knowingly sells, purchases, manufactures, 1084
delivers, or brings into this state, or who is knowingly in 1085
actual or constructive possession of, 7 grams or more of 1086
oxycodone, as described in s. 893.03(2)(a)1.q., or any salt 1087
thereof, or 7 grams or more of any mixture containing any such 1088
substance, commits a felony of the first degree, which felony 1089
shall be known as "trafficking in oxycodone," punishable as 1090
provided in s. 775.082, s. 775.083, or s. 775.084. If the 1091
quantity involved: 1092
a. Is 7 grams or more, but less than 14 grams, such person 1093
shall be sentenced to a mandatory minimum term of imprisonment 1094
of 3 years and shall be ordered to pay a fine of $50,000. 1095
b. Is 14 grams or more, but less than 25 grams, such 1096
person shall be sentenced to a mandatory minimum term of 1097
imprisonment of 7 years and shall be ordered to pay a fine of 1098
$100,000. 1099
c. Is 25 grams or more, but less than 100 grams, such 1100

CS/CS/HB 309 2026

CODING: Words stricken are deletions; words underlined are additions.
hb309-02-c2
Page 45 of 49
F L O R I D A H O U S E O F R E P R E S E N T A T I V E S

person shall be sentenced to a mandatory minimum term of 1101
imprisonment of 15 years and shall be ordered to pay a fine of 1102
$500,000. 1103
d. Is 100 grams or more, but less than 30 kilograms, such 1104
person shall be sentenced to a mandatory minimum term of 1105
imprisonment of 25 years and shall be ordered to pay a fine of 1106
$750,000. 1107
4.a. A person who knowingly sells, purchases, 1108
manufactures, delivers, or brings into this state, or who is 1109
knowingly in actual or constructive possession of, 4 grams or 1110
more of: 1111
(I) Alfentanil, as described in s. 893.03(2)(b)1.; 1112
(II) Carfentanil, as described in s. 893.03(2)(b)6.; 1113
(III) Fentanyl, as described in s. 893.03(2)(b)9.; 1114
(IV) Sufentanil, as described in s. 893.03(2)(b)30.; 1115
(V) A fentanyl derivative, as described in s. 1116
893.03(1)(a)63.; 1117
(VI) A controlled substance analog, as described in s. 1118
893.0356, of any substance described in sub-sub-subparagraphs 1119
(I)-(V); or 1120
(VII) A mixture containing any substance described in sub-1121
sub-subparagraphs (I)-(VI), 1122
1123
commits a felony of the first degree, which felony shall be 1124
known as "trafficking in dangerous fentanyl or fentanyl 1125

CS/CS/HB 309 2026

CODING: Words stricken are deletions; words underlined are additions.
hb309-02-c2
Page 46 of 49
F L O R I D A H O U S E O F R E P R E S E N T A T I V E S

analogues," punishable as provided in s. 775.082, s. 775.083, or 1126
s. 775.084. 1127
b. If the quantity involved under sub-subparagraph a.: 1128
(I) Is 4 grams or more, but less than 14 grams, such 1129
person shall be sentenced to a mandatory minimum term of 1130
imprisonment of 7 years, and shall be ordered to pay a fine of 1131
$50,000. 1132
(II) Is 14 grams or more, but less than 28 grams, such 1133
person shall be sentenced to a mandatory minimum term of 1134
imprisonment of 20 years, and shall be ordered to pay a fine of 1135
$100,000. 1136
(III) Is 28 grams or more, such person shall be sentenced 1137
to a mandatory minimum term of imprisonment of 25 years, and 1138
shall be ordered to pay a fine of $500,000. 1139
c. A person 18 years of age or older who violates sub-1140
subparagraph a. by knowingly selling or delivering to a minor at 1141
least 4 grams of a substance or mixture listed in sub-1142
subparagraph a. shall be sentenced to a mandatory minimum term 1143
of not less than 25 years and not exceeding life imprisonment, 1144
and shall be ordered to pay a fine of $1 million if the 1145
substance or mixture listed in sub-subparagraph a. is in a form 1146
that resembles, or is mixed, granulated, absorbed, spray-dried, 1147
or aerosolized as or onto, coated on, in whole or in part, or 1148
solubilized with or into, a product, when such product or its 1149
packaging further has at least one of the following attributes: 1150

CS/CS/HB 309 2026

CODING: Words stricken are deletions; words underlined are additions.
hb309-02-c2
Page 47 of 49
F L O R I D A H O U S E O F R E P R E S E N T A T I V E S

(I) Resembles the trade dress of a branded food product, 1151
consumer food product, or logo food product; 1152
(II) Incorporates an actual or fake registered copyright, 1153
service mark, or trademark; 1154
(III) Resembles candy, cereal, a gummy, a vitamin, or a 1155
chewable product, such as a gum or gelatin-based product; or 1156
(IV) Contains a cartoon character imprint. 1157
5. A person who knowingly sells, purchases, manufactures, 1158
delivers, or brings into this state, or who is knowingly in 1159
actual or constructive possession of, 30 kilograms or more of 1160
any morphine, opium, oxycodone, hydrocodone, codeine, 1161
hydromorphone, or any salt, derivative, isomer, or salt of an 1162
isomer thereof, including heroin, as described in s. 1163
893.03(1)(b), (2)(a), (3)(c)3., or (3)(c)4., or 30 kilograms or 1164
more of any mixture containing any such substance, commits the 1165
first degree felony of trafficking in illegal drugs. A person 1166
who has been convicted of the first degree felony of trafficking 1167
in illegal drugs under this subparagraph shall be punished by 1168
life imprisonment and is ineligible for any form of 1169
discretionary early release except pardon or executive clemency 1170
or conditional medical release under s. 947.149. However, if the 1171
court determines that, in addition to committing any act 1172
specified in this paragraph: 1173
a. The person intentionally killed an individual or 1174
counseled, commanded, induced, procured, or caused the 1175

CS/CS/HB 309 2026

CODING: Words stricken are deletions; words underlined are additions.
hb309-02-c2
Page 48 of 49
F L O R I D A H O U S E O F R E P R E S E N T A T I V E S

intentional killing of an individual and such killing was the 1176
result; or 1177
b. The person's conduct in committing that act led to a 1178
natural, though not inevitable, lethal result, 1179
1180
such person commits the capital felony of trafficking in illegal 1181
drugs, punishable as provided in ss. 775.082 and 921.142. A 1182
person sentenced for a capital felony under this paragraph shall 1183
also be sentenced to pay the maximum fine provided under 1184
subparagraph 1. 1185
6. A person who knowingly brings into this state 60 1186
kilograms or more of any morphine, opium, oxycodone, 1187
hydrocodone, codeine, hydromorphone, or any salt, derivative, 1188
isomer, or salt of an isomer thereof, including heroin, as 1189
described in s. 893.03(1)(b), (2)(a), (3)(c)3., or (3)(c)4., or 1190
60 kilograms or more of any mixture containing any such 1191
substance, and who knows that the probable result of such 1192
importation would be the death of a person, commits capital 1193
importation of illegal drugs, a capital felony punishable as 1194
provided in ss. 775.082 and 921.142. A person sentenced for a 1195
capital felony under this paragraph shall also be sentenced to 1196
pay the maximum fine provided under subparagraph 1. 1197
7. A person who knowingly sells, purchases, manufactures, 1198
delivers, or brings into this state, or who is knowingly in 1199
actual or constructive possession of, 28 grams or more of 1200

CS/CS/HB 309 2026

CODING: Words stricken are deletions; words underlined are additions.
hb309-02-c2
Page 49 of 49
F L O R I D A H O U S E O F R E P R E S E N T A T I V E S

xylazine, as described in s. 893.03(1)(c)37., or any salt 1201
thereof, or 28 grams or more of any mixture containing any such 1202
substance, commits a felony of the first degree, which felony 1203
shall be known as "trafficking in xylazine," punishable as 1204
provided in s. 775.082, s. 775.083, or s. 775.084. If the 1205
quantity involved: 1206
a. Is 28 grams or more, but less than 100 grams, such 1207
person shall be sentenced to a mandatory minimum term of 1208
imprisonment of 3 years and shall be ordered to pay a fine of 1209
$50,000. 1210
b. Is 100 grams or more, but less than 200 grams, such 1211
person shall be sentenced to a mandatory minimum term of 1212
imprisonment of 7 years and shall be ordered to pay a fine of 1213
$100,000. 1214
c. Is 200 grams or more, such person shall be sentenced to 1215
a mandatory minimum term of imprisonment of 25 years and shall 1216
be ordered to pay a fine of $500,000. 1217
Section 4. Except as otherwise expressly provided in this 1218
act and except for this section, which shall take effect upon 1219
this act becoming a law, this act shall take effect October 1, 1220
2026. 1221